IIIF provides researchers rich metadata and media viewing options for comparison of works across cultural heritage collections. Visit the IIIF page to learn more. The HeartMate II Left Ventricular ...
A multi-institution research effort led by Harvard Medical School, Boston, has looked into the safety and efficacy of excluding aspirin from the treatment of patients with advanced heart failure ...
Every year, around 50,000 people in the United States experience cardiogenic shock - a life-threatening condition, usually caused by a severe heart attack, in which the heart can't pump enough blood ...
If headlines about Abbott’s HeartMate 3 problems are giving you déjà vu, you’re not alone. With three recalls related to the left ventricular assist device (LVAD) so far this year, the news is ...
On July 29, a team from Emory’s Heart and Vascular Center completed its 500th continuous flow, durable left ventricular assist device (LVAD) implantation, further affirming Emory Healthcare’s status ...
The BrioVAD pump is the first implantable device from China to receive approval for clinical trials in America A "Chinese ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results